Headquarters
101 W. BIG BEAVER 10TH FLOOR, TROY, MI 48304, US
TROY, MI, US
CAEREGEN THERAPEUTICS LLC
From the company
RetiNova Therapeutics is developing a new class of regenerative therapies designed to reverse vision loss associated with retinal ischemia. Its Noregen™ (CTR-107) program, a synthetic protein modeled after norrin, is in late preclinical development for diabetic macular edema (DME) and retinal vein occlusion (RVO), aiming for disease modification and regeneration of functional retinal tissue.
Products & services offered
Capabilities 2
Classifications
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.